Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Knop, Filip K, Aroda, Vanita R, do Vale, Ruben D, Holst-Hansen, Thomas, Laursen, Peter N, Rosenstock, Julio, Rubino, Domenica M, Garvey, W Timothy
Published in The Lancet (British edition) (26.08.2023)
Published in The Lancet (British edition) (26.08.2023)
Get full text
Journal Article
Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity
Wilkinson, Lua, Holst‐Hansen, Thomas, Laursen, Peter N., Rinnov, Anders R., Batterham, Rachel L., Garvey, W. Timothy
Published in Obesity (Silver Spring, Md.) (01.09.2023)
Published in Obesity (Silver Spring, Md.) (01.09.2023)
Get full text
Journal Article
80-OR: Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis
KUSHNER, ROBERT F., DAVIES, MELANIE J., DEANFIELD, JOHN, GARVEY, W. TIMOTHY, JEPPESEN, OLE, KHALID, USMAN, KOSIBOROD, MIKHAIL N., LAURSEN, PETER N., RUBINO, DOMENICA, VERMA, SUBODH
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
927-P: Effect of Oral Semaglutide with or without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4
PRATLEY, RICHARD E., BAUER, ROBERT, INZUCCHI, SILVIO E., KHUNTI, KAMLESH, KREINER, ESKIL B., LAURSEN, PETER N., MEIER, JURIS J.
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
81-OR: Once-Weekly Semaglutide 2.4 mg Improved Glucose Metabolism and Prediabetes in Adults with Overweight/Obesity in the STEP 1 Trial
PERREAULT, LEIGH, DAVIES, MELANIE J., FRIAS, JUAN P., LAURSEN, PETER N., LINGVAY, ILDIKO, MACHINENI, SRIRAM, VARBO, ANETTE, WILDING, JOHN, WALLENSTEIN, SIGNE O.R., ROUX, CAREL LE
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial
Nepper-Christensen, Lars, Lønborg, Jacob, Ahtarovski, Kiril A, Høfsten, Dan E, Kyhl, Kasper, Schoos, Mikkel M, Göransson, Christoffer, Laursen, Peter N, Sadjadieh, Golnaz, Ghotbi, Adam Ali, Bertelsen, Litten, Køber, Lars, Helqvist, Steffen, Pedersen, Frants, Jørgensen, Erik, Kelbæk, Henning, Vejlstrup, Niels, Holmvang, Lene, Engstrøm, Thomas
Published in European heart journal. Acute cardiovascular care (01.06.2019)
Published in European heart journal. Acute cardiovascular care (01.06.2019)
Get full text
Journal Article
Treatment With Once-weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults With Overweight or Obesity and Type 2 Diabetes: STEP 2 Post Hoc Analysis
Lau, David, Deanfield, John E, Davies, Melanie, Garvey, Timothy W, Jeppesen, Ole K, Khalid, Usman, Kosiborod, Mikhail, Kushner, Robert F, Laursen, Peter N, Rubino, Domenica M, Verma, Subodh
Published in Canadian journal of diabetes (01.11.2022)
Published in Canadian journal of diabetes (01.11.2022)
Get full text
Journal Article